Home › Brain Tumors › Virginia
Brain Tumors clinical trials in Virginia
15 studies for Brain Tumors are looking for participants at sites in Virginia.
Cities in Virginia
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Inova Schar Cancer Institute, Fairfax
- VCU Massey Comprehensive Cancer Center, Richmond
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07326566C-SMART vs BE Well for Patients With Brain Tumors
- Virginia Commonwealth University, Richmond
Recruiting
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07224503Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- NEXT Virginia, Fairfax
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT05786924Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- Virginia Cancer Institute, Norfolk
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT05386108FearLess in NeuroOncology
- Virginia Commonwealth University, Richmond
Recruiting
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06989086A Phase 1/1b Study of IAM1363 in HER2 Cancers
- NEXT Oncology - Virginia Cancer Specialists, Fairfax
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06253871A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
- Inova Center for Personalized Health, Fairfax
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT07428616A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases
- Next Oncology -Virginia, Fairfax
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT06136884Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- INOVA Health, Fairfax
RecruitingObservational study
All ages · All sexes · Updated Jul 22, 2026 · NCT04427384Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- University of Virginia Comprehensive Cancer Center, Charlottesville
RecruitingPhase 2
Ages 18 and older · Women · Updated Jul 21, 2026 · NCT04348747Pain Control and Quality of Recovery After Intravenous Methadone Versus Intravenous Remifentanil in Craniotomy Surgery
- University of Virginia, Charlottesville
RecruitingEarly phase 1
Ages 18 to 65 · All sexes · Updated May 4, 2026 · NCT06810336Sonodynamic Therapy in Patients With Recurrent GBM
- University of Virginia, Charlottesville
RecruitingPhase 1
Ages 18 to 80 · All sexes · Updated Apr 28, 2026 · NCT06039709Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- NEXT Virginia, Fairfax
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT06810544S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- Augusta Health Center for Cancer and Blood Disorders, Fishersville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 8, 2025 · NCT03418961A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
- NEXT Virginia, Fairfax
RecruitingPhase 1/2
Ages 18 to 89 · All sexes · Updated Aug 19, 2025 · NCT06907043From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.